Join us for a Pink Ribbon Walk this spring Choose from 4 incredible walks, each in an iconic destination surrounded by spectacular scenery. 10 or 20 mile options are available.
Book a Public Health Talk Raise awareness of breast cancer in your local community or network by booking a free online or in-person talk.
Home About us Media Breast Cancer Now media statements 187 results Talazoparib (Talzenna) approved for use on the NHS in England 19 Jan 2024 2 min read Scottish Medicines Consortium (SMC) approves trastuzumab deruxtecan (Enhertu) for use on NHS in Scotland 11 Dec 2023 2 min read We respond to a policy review by leading cancer experts, published in The Lancet Oncology, on improving cancer care in the UK 15 Nov 2023 1 min read We respond to NHSE announcement of the license for anastrozole being extended to cover its use as a risk-reducing treatment for breast cancer 07 Nov 2023 1 min read Breast Cancer Now responds to research about polygenic risk score tests 18 Oct 2023 1 min read Breast Cancer Now responds to 'life-saving’ decision to approve olaparib for use on the NHS in Scotland 09 Oct 2023 2 min read We respond to the Scottish Health Technologies Group’s recommendation on tumour profiling tests for certain patients with primary breast cancer 06 Oct 2023 1 min read We respond to new research exploring if a robot device could potentially carry out a clinical breast exam 04 Oct 2023 1 min read We respond to provisional rejection of trastuzumab deruxtecan (Enhertu) for certain secondary breast cancer patients 26 Sept 2023 3 min read We respond to July’s cancer waiting times from NHS Wales 21 Sept 2023 1 min read We respond to July’s NHS England waiting times data 14 Sept 2023 2 min read We respond to new CRUK analysis revealing over a million lives have been saved over last four decades in the UK due to advances in cancer care 01 Sept 2023 1 min read Previous 1 ... 5 ... 16 Next
Scottish Medicines Consortium (SMC) approves trastuzumab deruxtecan (Enhertu) for use on NHS in Scotland 11 Dec 2023 2 min read
We respond to a policy review by leading cancer experts, published in The Lancet Oncology, on improving cancer care in the UK 15 Nov 2023 1 min read
We respond to NHSE announcement of the license for anastrozole being extended to cover its use as a risk-reducing treatment for breast cancer 07 Nov 2023 1 min read
Breast Cancer Now responds to 'life-saving’ decision to approve olaparib for use on the NHS in Scotland 09 Oct 2023 2 min read
We respond to the Scottish Health Technologies Group’s recommendation on tumour profiling tests for certain patients with primary breast cancer 06 Oct 2023 1 min read
We respond to new research exploring if a robot device could potentially carry out a clinical breast exam 04 Oct 2023 1 min read
We respond to provisional rejection of trastuzumab deruxtecan (Enhertu) for certain secondary breast cancer patients 26 Sept 2023 3 min read
We respond to new CRUK analysis revealing over a million lives have been saved over last four decades in the UK due to advances in cancer care 01 Sept 2023 1 min read
